IRIS
FABRAZZO, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.429
NA - Nord America 6.819
AS - Asia 3.733
SA - Sud America 590
Continente sconosciuto - Info sul continente non disponibili 176
AF - Africa 42
OC - Oceania 3
Totale 22.792
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.690
RU - Federazione Russa 5.978
IT - Italia 1.955
SG - Singapore 1.560
IE - Irlanda 1.097
CN - Cina 739
UA - Ucraina 593
HK - Hong Kong 581
BR - Brasile 519
GB - Regno Unito 492
VN - Vietnam 317
DE - Germania 298
FR - Francia 295
SE - Svezia 281
FI - Finlandia 150
TR - Turchia 127
JP - Giappone 104
IN - India 101
GR - Grecia 98
KR - Corea 79
CA - Canada 54
NL - Olanda 46
PL - Polonia 36
BD - Bangladesh 27
AR - Argentina 21
BE - Belgio 21
AT - Austria 17
CH - Svizzera 16
ID - Indonesia 15
IQ - Iraq 14
ZA - Sudafrica 14
MX - Messico 13
CO - Colombia 12
ES - Italia 12
EC - Ecuador 10
TT - Trinidad e Tobago 10
CR - Costa Rica 9
NI - Nicaragua 9
PY - Paraguay 9
VE - Venezuela 9
RO - Romania 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
JM - Giamaica 7
MA - Marocco 7
PR - Porto Rico 7
UZ - Uzbekistan 7
EG - Egitto 6
GT - Guatemala 6
MY - Malesia 6
PK - Pakistan 6
PT - Portogallo 6
CL - Cile 5
CW - ???statistics.table.value.countryCode.CW??? 5
CZ - Repubblica Ceca 5
KE - Kenya 5
LB - Libano 5
LT - Lituania 5
PH - Filippine 5
SV - El Salvador 5
DZ - Algeria 4
EU - Europa 4
HN - Honduras 4
RS - Serbia 4
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
OM - Oman 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
GP - Guadalupe 2
KZ - Kazakistan 2
NO - Norvegia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
EE - Estonia 1
ET - Etiopia 1
IS - Islanda 1
KG - Kirghizistan 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MR - Mauritania 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SI - Slovenia 1
UY - Uruguay 1
Totale 22.625
Salva come PNG Salva come JPEG
Città #
Moscow 2.211
Dublin 1.078
Jacksonville 881
Santa Clara 750
San Jose 623
Ashburn 593
Singapore 580
Hong Kong 576
Chandler 542
Council Bluffs 355
Princeton 183
Milan 182
Beijing 140
Roxbury 136
Ho Chi Minh City 120
Rome 116
Ann Arbor 96
Medford 91
Cambridge 89
Woodbridge 89
Boardman 84
Naples 83
New York 81
The Dalles 77
Seoul 74
Caserta 73
Wilmington 70
Bremen 68
Hanoi 65
Dallas 62
Hefei 54
Bengaluru 51
San Mateo 49
Nanjing 44
São Paulo 41
Los Angeles 40
Aversa 37
Des Moines 37
Miano 36
Munich 34
Seattle 34
Düsseldorf 27
Da Nang 23
Houston 23
Norwalk 22
Tokyo 22
Florence 21
Catania 20
Atlanta 19
Brussels 19
Bari 18
Jinan 18
Mountain View 18
Bologna 17
Brooklyn 17
Frankfurt am Main 17
Marigliano 17
Padova 17
Napoli 16
Palermo 15
Chicago 14
Nuremberg 14
Orem 13
Perugia 13
Radomsko 13
San Francisco 13
Shenyang 13
Torino 13
Warsaw 13
Denver 12
Fisciano 12
Haiphong 12
Montreal 12
Rio de Janeiro 12
Turin 12
Chennai 11
Hangzhou 11
Vienna 11
Brasília 10
Curitiba 10
Helsinki 10
Memphis 10
Porto Alegre 10
Tianjin 10
Auburn Hills 9
Belo Horizonte 9
Nanchang 9
Salerno 9
Toronto 9
Cagliari 8
Como 8
Genoa 8
Genova 8
Managua 8
North Bergen 8
San José 8
Taranto 8
Viterbo 8
Catanzaro 7
Ferrara 7
Totale 11.406
Salva come PNG Salva come JPEG
Nome #
SINDROME METABOLICA E TRATTAMENTO CON ANTIPSICOTICI: DIFFERENZE IN PAZIENTI CON DIAGNOSI DI SCHIZOFRENIA E DISTURBO BIPOLARE 679
Discrasie ematiche transitorie e persistenti indotte dalla clozapina durante le prime diciotto settimane di trattamento 555
CLOZAPINA E ALTRI ANTIPSICOTICI ATIPICI E TIPICI: INCIDENZA E DECORSO DELLE DISCRASIE EMATICHE DURANTE LE PRIME DICIOTTO SETTIMANE DI TRATTAMENTO 279
Duration of Untreated Illness in Patients with Obsessive-Compulsive Disorder and Its Impact on Long-Term Outcome: A Systematic Review 237
Trattamento combinato con clorimipramina ed aripiprazolo nella depressione resistente 234
TRATTAMENTO CON ANTIPSICOTICI E COMPARSA DI SINDROME METABOLICA: UNO STUDIO RETROSPETTIVO IN PAZIENTI SCHIZOFRENICI E BIPOLARI 202
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa 201
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 196
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: An open preliminary study. 190
Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature review 188
Brain natriuretic peptide as a biomarker of asymptomatic clozapine-related heart dysfunction: a criterion for a more cautious administration. 186
Vitamin D Deficiency and Risk Factors Related to Acute Psychiatric Relapses in Patients with Severe Mental Disorders: A Preliminary Study 180
Magnetic resonance imaging of a transient splenial lesion of the corpus callosum resolved within a week 175
Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature 169
Sindrome metabolica e utilizzo di antipsicotici in pazienti con diagnosi di schizofrenia e disturbo bipolare 167
Antipsychotic treatment and metabolic syndrome: a retrospective study in schizophrenic and bipolar patients 167
Cancro della mammella e Alessitimia: Freno o Incentivo alla prevenzione? 167
Trattamento con antipsicotici e sindrome metabolica: uno studio retrospettivo in pazienti schizofrenici e bipolari 165
Antipsychotic treatment and metabolic syndrome: a retrospective study in schizophrenic and bipolar patients 162
L’Olanzapina è più rapida dell’Aloperidolo nell’indurre Sindrome Metabolica in pazienti schizofrenici ma non nei bipolari 162
Antipsychotic Treatment and Metabolic Syndrome: a Comparison between Schizophrenic and Bipolar Patients. 161
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study 161
Transient and persistent blood dyscrasias induced by clozapine during the first 18 weeks of treatment 157
A hypothesis on Cotard’s syndrome as an evolution of obsessive-compulsive disorder 156
The unmasking of hidden severe hyponatremia after long-term combination therapy in exacerbated bipolar patients: a case series. 153
Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa 152
Aumento dei livelli plasmatici di colesterolo e trigliceridi nella bulimia nervosa 152
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports 152
Second-Generation Antipsychotics' Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders 150
Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa 150
Clozapine versus other antipsychotics during the first 18 weeks of treatment: A retrospective study on risk factor increase of blood dyscrasias 149
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study 149
Are antipsychotics useful in the treatment of anorexia nervosa? A review of the literature 147
Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients 146
Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological Mechanisms 145
La depressione resistente al trattamento farmacologico: incremento dell’effetto antidepressivo della clorimipramina determinato dall’aripiprazolo 145
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 144
Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment 143
Drug safety warnings in psychiatry: Adverse drug reactions' signaling from 2002 to 2014 143
Brain-derived neurotrophic factor (BDNF) nello spettro del comportamento alimentare 141
Molecular Psychiatry: regulation of gene function 141
Social Cognition Individualized Activities Lab for Social Cognition Training and Narrative Enhancement in Patients With Schizophrenia: A Randomized Controlled Study to Assess Efficacy and Generalization to Real-Life Functioning (Prot. n°: NCT05130853) 140
Correlati neurofisiologici della risposta clinica ai neurolettici tipici in pazienti schizofrenici al primo episodio di malattia 139
From over- to under-weight: treatment of post-surgical anorexia nervosa in morbid obesity 138
In rats the reserpine induced increase of brain NGF biosynthesis is mediated by corticosteroids 138
Pronounced, early increase in circulating leptin predicts lower weight gain during clozapine treatment 137
Factors Associated with Anxiety, Depression, and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study 136
Risposta al trattamento con inibitori del reuptake della serotonina nel disturbo ossessivo-compulsivo ad esordio precoce 135
Metabolic Syndrome and Antipsychotic treatment: how about schizophrenia and bipolar disorder? 135
Changes of cholinergic, noradrenergic and serotonergic synaptic transmission indices elicited by Ethylcholine Aziridinium ion (AF64A) infused intraventricularly 134
Add-on oral olanzapine worsens hallucinations in schizoaffective disorder. 134
Pemphigus and skin disease: A comparison of the incidence of stressful life events and personality disorders 133
Altered ghrelin physiology in bulimia nervosa: integration with leptin changes 132
Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. 130
Discrasie ematiche transitorie e persistenti e trattamento con clozapina nelle prime diciotto settimane di terapia 130
At the Core of Depression: A Diagnostic Interview of the Core Features of Depression 128
Duration of untreated illness and outcome of the OCD: a three-year prospective study 127
Duration of untreated illness and outcome of obsessive-compulsive disorder: A naturalistic follow-up study. 127
Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder 126
Transsynaptic regulation of nerve growth factor gene expression 125
Comorbidity of obsessive-compulsive disorder and schizotypal personality disorder: Clinical response and treatment resistance to pharmacotherapy in a 3-year follow-up naturalistic study 125
Il trattamento farmacologico dei sintomi negativi della schizofrenia 124
Safety and Tolerability of Mood Stabilisers 124
Regulation of nerve growth factor receptor mRNA content by dexamethasone: in vitro and in vivo studies 123
Clozapine treatment and other atypical and typical antipsychotics: incidence and course of blood dyscrasias during the first eighteen weeks of treatment 123
Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar Patients 123
Long-term pharmacological treatment in schizophrenia 121
Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine 121
La sindrome metabolica e l’utilizzo di antipsicotici: quali differenze in schizofrenia e disturbo bipolare? 121
Clinical and neurophysiological findings in schizophrenic patients with enlarged and normal ventricles 121
L'anoressia mentale: aspetti eziopatogenetici clinici e terapeutici 121
Studio longitudianle dei livelli plasmatici del cortisolo e delle catecolamine e della risposta al test al desametazone in pazienti con disordine affettivo bipolare 120
Leptin production in Bulimia Nervosa 118
L'ansia , la depressione e il movimento nell'anziano 117
Livelli plasmatici di TNF alfa in pazienti schizofrenici 117
Il monitoraggio plasmatico della clozapina e dei suoi principali metaboliti in pazienti schizofrenici 117
Livelli plasmatici degli aminoacidi nei pazienti affetti da schizofrenia cronica. 116
Sciatic nerves transplanted into the CNS exhibit elevated nerve growth factor (NGF) protein levels 116
Il monitoraggio plasmatico della clozapina e dei suoi principali metaboliti in pazienti schizofrenici 116
Response to lithium prophylaxis in schizoaffective psychoses 115
Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment 115
Effect of treatment duration on plasma levels of clozapine and n-desmethylclozapine in men and women 115
Peripheral brain derived neurotrophic factor (BDNF) in patients with unipolar depression or with bipolar I and II disorders 115
Pharmacology of Nerve Growth Factor biosynthesis in rat brain 115
La regolazione della sintesi del Nerve Growth factor nel Sistema Nervoso Centrale: gli steroidi come potenziali mediatori 115
Induction of Nerve Growth Factor gene expression by Beta-adrenergic receptor activation 114
Sistemi di classificazione e nosografia dei disturbi psichiatrici 114
Opposite modifications in circulating leptin and solubile leptin receptor across the eating disorder spectrum 113
I neurosteroidi ed il recettore periferico delle benzodiazepine 112
Una strategia di trattamento combinato con cloripramina ed aripiprazolo nella depressione resistente 112
Disturbo ossessivo-compulsivo ad esordio precoce: caratteristiche cliniche e risposta al trattamento 112
Gli endocannabinoidi nei disturbi del comportamento alimentare: implicazioni fisiopatologiche 112
Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge eating disorder: relationships to comorbid depression, psychopathology and hormonal variables 111
Neuroendocrine findings in obsessive-compulsive disorder: implications for drug treatment 111
Plamsa leptin response to acute fasting and refeeding in untreated women with bulimia nervosa 111
Obsessive-compulsive disorder with poor insight: A three-year prospective study. 111
Regulation of Nerve Growth Factor receptor biosynthesis: in vitro and in vivo studies 111
Neonatal mild stress influences the programming of some adult cerebral biochemical structures 111
Long-term treatment with clozapine does not affect morning circulating levels of allopregnanolone and THDOC in patients with schizophrenia: a preliminary study 110
Transcriptional regulation of Nerve Growth Factor gene 110
Totale 14.971
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.084
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.100 0 0 0 38 435 20 25 44 53 61 90 334
2022/20232.183 187 59 48 160 259 182 4 124 1.042 17 54 47
2023/2024991 80 27 81 76 287 58 35 60 14 26 84 163
2024/20252.766 22 36 49 76 428 394 230 203 413 555 206 154
2025/20269.674 328 315 387 440 812 5.600 495 293 419 287 178 120
2026/20271.904 149 302 752 701 0 0 0 0 0 0 0 0
Totale 22.792